Virtu Financial’s Eledon Pharmaceuticals ELDN Stock Holding History

Virtu Financial’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$158K	Buy	+40,043	New	+$146K	0.01%	1010
2026 Q1	–	Sell	-25,920	Closed	-$39K	–	1807
2025 Q4	$39K	Buy	+25,920	New	+$61.6K	﹤0.01%	1334
2025 Q1	–	Sell	-20,016	Closed	-$82K	–	1532
2024 Q4	$82K	Buy	+20,016	New	+$78.9K	﹤0.01%	1065
2023 Q3	–	Sell	-17,675	Closed	-$24K	–	1453
2023 Q2	$24K	Buy	+17,675	New	+$36.8K	﹤0.01%	1231
2021 Q4	–	Sell	-18,610	Closed	-$115K	–	1840
2021 Q3	$115K	Buy	+18,610	New	+$130K	0.01%	1099
2020 Q3	–	Sell	-5,117	Closed	-$42K	–	1184
2020 Q2	$42K	Buy	+5,117	New	+$57.7K	﹤0.01%	1025
2019 Q4	–	Sell	-784	Closed	-$9K	–	1528
2019 Q3	$9K	Sell	784 -1,756	-69%	-$25.2K	﹤0.01%	1354
2019 Q2	$46K	Buy	+2,540	New	+$111K	﹤0.01%	1253

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Virtu Financial's ELDN Position: Q2 2026 in Review

Virtu Financial opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 40,043 shares worth $158K. The stake represents 0.01% of the portfolio and ranks #1010 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ELDN as recently as Q4 2025.

Virtu Financial first reported a position in ELDN in Q2 2019 and has held it in 8 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Virtu Financial held 40,043 shares of Eledon Pharmaceuticals worth $158K as of Q2 2026.
Eledon Pharmaceuticals was a new Virtu Financial position in Q2 2026.
Eledon Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #1010 holding.
Virtu Financial first reported a position in Eledon Pharmaceuticals in Q2 2019 and has held it in 8 quarters since.
160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.